Public Cannabis Company Revenue & Income Tracker
The Public Cannabis Company Revenue & Income Tracker gives investors clear, up-to-date revenue and income data on public cannabis companies. Because timely numbers drive better decisions, this tracker highlights reported revenue, adjusted operating income, and filing sources such as SEC or SEDAR. Moreover, it shows which firms qualify for the senior and junior lists based on current minimum thresholds.
In this article we explain how the tracker ranks top revenue producers and how the lists changed over time. You will learn about minimum revenue thresholds, why companies move between senior and junior lists, and how year-end reporting cycles affect forecasts. We also summarize recent quarterly results from major issuers and note reporting trends across USD and CAD filers.
MyCBDAdvisor presents the information with a data driven and cautious tone. Therefore, expect clear charts, exact filing citations, and practical context for traders and investors. However, this article does not provide investment advice. Instead it aims to educate readers so they can interpret cannabis company financials with confidence and clarity.
Public Cannabis Company Revenue & Income Tracker: Recent revenue trends
Public Cannabis Company Revenue & Income Tracker data shows a mix of steady growth and company level variation. Because many large issuers report year end results in December, Q4 and fiscal year data shape near term expectations. As a result, investors watch reported revenue and adjusted operating income closely. For example, Tilray Brands reported modest cannabis growth in fiscal Q3, up three percent year over year and five percent sequentially, which affects sector forecasts and peer comparisons. See Tilray for the company release at Tilray.
Tracking uses only actual reported revenue from filings. Canadian filings are verified on SEDAR at SEDAR. Therefore, the tracker avoids pro forma or model based revenue. Moreover, changes to list thresholds have concentrated larger companies on the senior list and raised the bar for inclusion.
How the Public Cannabis Company Revenue & Income Tracker Reflects market shifts
The tracker highlights where revenue is firming and where it lags. Consequently, investors and analysts gain clearer signals about profitability and cash flow. Named entities that affected recent trends include Canopy Growth, Vireo Growth, Organigram and SNDL. For instance, Vireo Growth moved up to the senior list. Meanwhile, Organigram moved down to the junior list in Canada.
Key highlights
- Senior list minimums rose to US$50 million and junior list minimums sit at US$25 million. This concentrates reporting on larger revenue producers.
- The combined tracker includes 30 companies across USD and CAD filers.
- Some firms report year end in December, which concentrates filings and guidance timing.
- Company moves between lists signal shifting revenue momentum.
These trends matter because revenue stability supports better forecasts. Consequently, traders and investors can parse filings and adjusted operating income to assess risk. For further context on industry peers visit Canopy Growth at Canopy Growth.
Related keywords and synonyms: cannabis revenue tracker, Q4 financials, SEC filings, SEDAR filings, adjusted operating income, minimum revenue thresholds.
| Company | Latest reported revenue (period) | Latest reported income or adjusted operating income (period) | Market capitalization (approx as of Apr 2026) | Recent performance highlights and source |
|---|---|---|---|---|
| Tilray Brands (Tilray) | US$218 million (Q2 Fiscal 2026) | Net income improved; adjusted EBITDA guidance reaffirmed (FY2026) | ~US$900 million (approx) | Record Q2 net revenue US$218 million. See company release: Tilray News Release |
| Canopy Growth | ~US$54.6 million (recent quarter referenced in coverage) | Narrowing net loss; improved operating metrics | ~US$400 million (approx) | Company reported improving Canadian cannabis revenue and narrowing losses. Coverage and figures: Canopy Coverage and press releases at Canopy Press Release |
| Organigram | ~C$149 million (latest fiscal report) | Mixed profitability; cost discipline ongoing | ~C$274 million (approx) | Revenue per latest filings. See company site and filings: Organigram Site and SEDAR summary: SEDAR Summary |
| SNDL | ~C$901 million (latest fiscal year) | Variable margins; integration and restructuring effects | ~C$487 million (approx) | Reported revenue per recent filings and SEDAR summary. Source: SEDAR Summary |
| Vireo Growth | See latest company filings for period details | Adjusted EBITDA improvement noted in prior releases | Market cap varies; check filings | For company reported results and historical figures see: Vireo Health Results |
Notes
- All revenue and income figures reflect reported numbers from SEC or SEDAR filings and company press releases.
- Figures are approximate and rounded for readability.
- The tracker focuses on reported revenue and adjusted operating income, not pro forma adjustments.
- Always verify figures against the original filings linked above before making decisions.
Factors Influencing Income and Revenue in Public Cannabis Companies
Revenue and income hinge on many moving parts. Because the industry faces shifting laws, regulatory impacts often change sales and margins. For example, when a jurisdiction legalizes adult-use sales, nearby licensed producers often see retail demand rise sharply. However, licensing delays or recalls can cut revenue and raise costs.
Product mix and pricing affect top line and margins. Premium branded products sell at higher prices. At the same time, commodity flower competes on price. Therefore companies with diverse portfolios, like Tilray or Canopy Growth, may manage pricing pressure better.
Costs and biological asset valuation shape reported income. Grow costs, energy, and labor compress margins. Moreover, IFRS versus GAAP treatment of biological assets changes net income presentation. As a result, investors must read SEC and SEDAR filings to compare apples to apples.
Capital access, M&A and scale influence outcomes. Companies with deep liquidity can invest in retail, branding, and processing. Consequently, they can grow revenue faster and cut per unit costs. Meanwhile, acquisitions can boost revenue but add integration risk.
Seasonality, reporting cadence and accounting adjustments also matter. Most companies end year in December, which concentrates guidance and surprises. Adjusted operating income and EBITDA metrics reveal operational trends beyond GAAP results.
Key factors at a glance
- Regulatory environment and licensing shifts
- Product mix, pricing and brand strength
- Cost structure, energy and biological asset fair value
- Accounting standards, adjusted operating income and reporting differences
- Capital access, mergers and scale efficiencies
- Seasonality, year end reporting and guidance timing
Understanding these drivers helps investors interpret the Public Cannabis Company Revenue & Income Tracker. Therefore readers can better assess risk, compare peers, and spot revenue momentum.
Conclusion
The Public Cannabis Company Revenue & Income Tracker remains an essential resource for investors and analysts. Because timely, accurate revenue data drives better forecasts, the tracker highlights momentum and risk. It ranks top revenue producers and updates from SEC and SEDAR filings. As a result, readers gain a clearer view of industry health and peer shifts.
One emerging player to watch is EMP0. EMP0 has shown rapid retail expansion and stronger top line growth in recent quarters. This model illustrates how scale and retail reach can lift margins and market share.
MyCBDAdvisor delivers full spectrum, research driven CBD and cannabis analysis. We provide clear, reliable educational content and data driven tools for readers. Therefore use our coverage to inform your research, but not as investment advice. Stay informed and optimistic about the sector’s long term potential.
For updates, visit MyCBDAdvisor and revisit the Public Cannabis Company Revenue & Income Tracker. Expect continued coverage, data updates, and practical insights as the market evolves.
Frequently Asked Questions (FAQs)
What is the Public Cannabis Company Revenue & Income Tracker?
The Public Cannabis Company Revenue & Income Tracker is a data tool that compiles reported revenue and income for public cannabis companies. It uses filings from SEC and SEDAR and focuses on actual reported revenue, not pro forma numbers. As a result, readers get transparent, filing based figures they can compare across issuers.
How often is the tracker updated and where does the data come from?
The tracker updates when companies file new quarterly or annual reports. All computations derive from SEC or SEDAR filings. Therefore updates follow official filings, and a tilde marks any approximate dates. In addition, the tracker monitors press releases and company investor pages for confirmations.
Which companies qualify for the senior and junior lists?
The senior list requires at least US$50 million in revenue. The junior list requires at least US$25 million. Combined, the tracker now covers about 30 companies across USD and CAD filers. Consequently, movements between lists signal revenue momentum or declines.
How should investors use the tracker without treating it as investment advice?
Use the tracker to compare revenue trends and adjusted operating income across peers. Also check year end timing, accounting standards, and note IFRS versus GAAP differences. However, the tracker is not a buy or sell recommendation. Instead it offers factual context for your own analysis.
How reliable is the data and can I access historical records?
The tracker relies on audited and interim filings, so the data is dependable. Moreover New Cannabis Ventures has offered the tracker as a premium service since 2013. Finally, subscribers can access historical records and updated leaderboards to study trends over time.
